Evidence map›Paper›PMID 40504156›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Pathogenic variants in the polycystin pore helix cause distinct forms of channel dysfunction.

Orhi Esarte Palomero, Eduardo Guadarrama, Paul G DeCaen

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Orhi Esarte PalomeroDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60061.
Eduardo GuadarramaDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60061.
Paul G DeCaenDepartment of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60061.ORCID 0000-0001-8776-983X

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
Training Core for Chicago KUH FORWARDTL1DK132769 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Tamara Isakova · 2021 to 2026
$4.0M
Professional Development Core for Chicago KUH FORWARDU2CDK129917 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARLENE B CHAPMAN, David J Klumpp · 2021 to 2026
$2.9M
Molecular dysregulation of primary cilia TRPP2 channels caused by Finger 1 variantsR01DK123463 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DECAEN, PAUL GREGORY · 2019 to 2023
$2.0M
Cilia calcium dysregulation in polycystic kidney diseaseR01DK131118 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Paul Gregory DeCaen · 2022 to 2026
$1.9M
Polycystin glycosylation regulation and dysregulation in ADPKDF32DK137477 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ESARTE PALOMERO, ORHI · 2024 to 2024
$77k
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK123463HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK131118HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) F32DK137477HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) TL1DK132769NCI NIH HHS P30 CA060553NIDDK NIH HHS F32 DK137477NIDDK NIH HHS R01 DK123463NIDDK NIH HHS R01 DK131118NIDDK NIH HHS TL1 DK132769NIDDK NIH HHS U2C DK129917NIGMS NIH HHS U24 GM129547
6 · The paper itself

Abstract

PKD2 is a member of the polycystin subfamily of transient receptor potential (TRP) ion channel subunits which traffic and function in primary cilia organelle membranes. Millions of individuals carry pathogenic genetic variants in PKD2 that cause a life-threatening condition called autosomal dominant polycystic kidney disease (ADPKD). Although ADPKD is a common monogenetic disorder, there is no drug cure or available therapeutics which address the underlying channel dysregulation. Furthermore, the structural and mechanistic impacts of most disease-causing variants are uncharacterized. Using direct cilia electrophysiology, cryogenic electron microscopy (cryo-EM), and superresolution imaging, we have found mechanistic differences in channel dysregulation caused by three germline missense variants located in PKD2's pore helix 1. Variant C632R reduces protein thermal stability, resulting in impaired channel assembly and abolishes primary cilia trafficking. In contrast, variants F629S and R638C retain native cilia trafficking but exhibit gating defects. Cryo-EM structures (2.7 to 2.8 Å resolution) indicate loss of critical pore helix interactions which precipitate allosteric collapse of the channels inner gate. Results demonstrate how ADPKD-causing mutations cause mechanistically divergent and ranging impacts on PKD2 function, despite their shared structural proximity. These unexpected findings highlight the need for structural and biophysical characterization of polycystin variants, which will guide rational drug development of ADPKD therapeutics.

Indexed as

Polycystic Kidney, Autosomal DominantTRPP Cation ChannelsAnimalsCiliaCryoelectron MicroscopyHEK293 CellsHumansIon Channel GatingMutation, MissenseTRPP Cation Channelsautosomal polycystic kidney diseasecryo-EMpolycystinTRP channels

Identifiers

PMID40504156
PMCPMC12184499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.